I feel this has surely got to be an over reaction.
The data supports the benefit of the technology for breast cancer survivors. With a new CEO and marketing team, surely it can only be up from now. Nothing else has really changed. The product is good, just needs sales and uptakes.
I feel this has surely got to be an over reaction. The data...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AXP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.824M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.1¢ | $3.052K | 1.651M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 43009120 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 90779583 | 59 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| AXP (ASX) Chart |
